BRAFV600E mCRC: No survival benefit of FOLFOXIRI+anti-VEGF over doublet+anti-VEGFSeptember 16, 2022Gastrointestinal Cancer
Stage II/III rectal cancer: Shift in treatment pattern and outcomesSeptember 16, 2022Gastrointestinal Cancer
Early rectal cancer: Neoadjuvant chemotherapy may reduce need for invasive surgeriesSeptember 16, 2022Gastrointestinal Cancer
Oncology PracticeWalking intensity and step count are linked to health benefitsSeptember 15, 2022Preventive Care
Oncology PracticeTime to cancer diagnoses in U.S. averages 5 monthsSeptember 15, 2022Breast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
Hematology NewsNewborns get routine heel blood tests, but should states keep those samples?September 15, 2022PediatricsBusiness of Medicine
Hematology NewsNew ESC guidelines for cutting CV risk in noncardiac surgerySeptember 15, 2022Preventive CareThrombosis
Oncology PracticeOpioids after lung cancer surgery may up all-cause mortality riskSeptember 15, 2022Lung Cancer
Oncology PracticeAnnual screening benefits people at high-risk for pancreatic cancerSeptember 14, 2022Gastrointestinal CancerGastroenterology
Oncology PracticeNot just what, but when: Neoadjuvant pembrolizumab in melanomaSeptember 14, 2022Melanoma
Oncology PracticeCould nivolumab prevent oral cancer in high-risk patients?September 14, 2022Lung Cancer
Oncology Practice‘Unprecedented’ responses to neoadjuvant treatment in dMMR colon cancerSeptember 14, 2022Gastrointestinal Cancer
